These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 403459)

  • 1. [Resistance testing of malignant tumors].
    Volm M; Ehrhart H
    MMW Munch Med Wochenschr; 1977 Mar; 119(9):Suppl. 7-8. PubMed ID: 403459
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug resistance of human tumors: from the laboratory to the clinic].
    Mousseau M
    Bull Cancer; 1994 Dec; 81 Suppl 2():53s-54s. PubMed ID: 7727859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug treatment principles in malignant tumors of children].
    Gusev LI; Smirtiukov SV; Badolian GKh
    Feldsher Akush; 1983; 48(7):34-7. PubMed ID: 6555092
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molecular-genetic aspects of drug therapy of malignant tumors].
    Seĭts IF
    Eksp Onkol; 1987; 9(6):3-11. PubMed ID: 3325267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of drug resistance in human tumors using immunohistochemical techniques.
    Mattern J; Volm M
    Anticancer Res; 1992; 12(2):413-8. PubMed ID: 1349793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro resistance testing of tumors in relation to cytostatics. 2. Examinations with human malignomas].
    Possinger K; Hartenstein R; Ehrhart H
    Onkologie; 1980 Dec; 3(6):297-300. PubMed ID: 7012727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug resistance and a strategy to eradicate resistant malignant cells].
    Shimoyama M
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1280-2. PubMed ID: 2730026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experiences with vincristine sulfate in the therapy of malignant tumors].
    Hartwich G; Richter K; Lutz H
    Fortschr Med; 1972 Dec; 90(35):1305-9. PubMed ID: 4572046
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acquirement of drug resistance and angiogenesis in tumors].
    Kuwano M
    Fukuoka Igaku Zasshi; 1993 Sep; 84(9):377-82. PubMed ID: 7693562
    [No Abstract]   [Full Text] [Related]  

  • 10. Human tumor stem cell clonogenic assay sensitivity in malignant tumors and clinical correlation.
    Banerjee TK; Marx JJ; Spencer SK; Tiffany E
    Wis Med J; 1982 Dec; 81(12):19-22. PubMed ID: 6760565
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasmapheresis: First clinical results in malignant tumors].
    Beyer JH; Schuff-Werner P; Kaboth U; Klee M; Köstering H; Nagel GA
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1522-4. PubMed ID: 7313622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of multi-drug resistance in genito-urinary tumors].
    Theyer G; Hamilton G
    Prog Urol; 1993 Jun; 3(3):385-92; discussion 392-3. PubMed ID: 8103698
    [No Abstract]   [Full Text] [Related]  

  • 13. [The prediction of the individual chemosensitivity of human malignant tumors: the biological patterns and clinical results].
    Chissov VI; Sergeeva NS; Borisov VI; Skotnikova OI; Sviridova IK
    Eksp Klin Farmakol; 1995; 58(1):11-5. PubMed ID: 7787684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pretherapeutical testing of antineoplastic drugs in vitro (author's transl)].
    Projan A; Tanneberger S; Peek U; Nissen E
    Arch Geschwulstforsch; 1982; 52(1):1-7. PubMed ID: 7082128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reversal of drug resistance and prediction of the response to cytostatics. Experimental drug therapy for tumors has clinical potential].
    Larsson R; Nygren P; Bergh J
    Lakartidningen; 1991 Dec; 88(51-52):4441-4. PubMed ID: 1774991
    [No Abstract]   [Full Text] [Related]  

  • 16. The genetic origin of drug resistance in neoplasms: implications for systemic therapy.
    Goldie JH; Coldman AJ
    Cancer Res; 1984 Sep; 44(9):3643-53. PubMed ID: 6744284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative model for multiple levels of drug resistance in clinical tumors.
    Goldie JH; Coldman AJ
    Cancer Treat Rep; 1983 Oct; 67(10):923-31. PubMed ID: 6627236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug resistance in malignant neoplasms].
    Czownicki Z
    Pol Tyg Lek; 1982 Apr; 37(6):173-5. PubMed ID: 7122313
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor cell drug resistance and its reversal.
    Mansouri A; Henle KJ; Nagle WA; Moss AJ
    SAAS Bull Biochem Biotechnol; 1990 Jan; 3():91-6. PubMed ID: 1366508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modes of resistance to antitumor agents.
    Kessel D
    In Vivo; 1994; 8(5):829-34. PubMed ID: 7727732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.